πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 144 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11813485

Systems and methods for histotripsy immunosensitization

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11801241

Muscarinic M2 receptor blockade to delay or prevent onset of progressive memory decline

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11793860

Vault complexes for cytokine delivery

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11787840

Compositions and methods for treating and preventing autoimmune induced cardiac long QT sy

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11766403

Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11760789

Broadly neutralizing antibodies against HIV

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11744831

Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infec

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11730705

Small molecule CMKLR1 antagonists in inflammatory disease

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11707459

Method for treating nervous system injuries using boldine and analogs thereof

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11690895

Compositions and methods of interferon alpha binding proteins

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11679121

Morpholino oligonucleotides useful in cancer treatment

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11672801

Compositions and methods for treating cancer

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11643394

KrΓΌppel-like factor 15 (KLF15) small molecule agonists in kidney disease

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11623918

Compounds for the treatment of acute and chronic kidney disease

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11607426

Method of targeting oncolytic viruses to tumors

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11578315

Truncated guinea pig L-asparaginase variants and methods of use

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11559565

Methods for treating inflammatory disorders and traumatic brain injury using stabilized no

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11523613

Ferrate compositions for surface disinfection

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11510887

Sobetirome in the treatment of myelination diseases

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11512052

Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11497739

Materials and methods for diagnosis, prevention and/or treatment of stress disorders and c

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11465972

Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11453725

Methods for DNA-dependent targeting of a cell permeant antibody

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11446331

Wound healing and tissue engineering

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted